Gene and Protein modifying enzymes, such as DNA methyltransferases (DNMT) and histone deacetylases (HDACs), are key enzymes overexpressed during HCC progression and may therefore serve as important targets for the development of alternative anticancer therapies for HCC. The gene discussed is DNMT1; the disease is hepatocellular carcinoma.